SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.33-8.2%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (10203)5/26/1999 8:12:00 PM
From: Bluegreen  Read Replies (1) of 17367
 
You stated>>>>>Final distribution of patients is not necessarily equal on each of the two Glasgow scores groups, and it is not equal either on the sudivision for treatment and placebo. A significant higher number of patients in the treatment group could happen by chance and very low number of deaths if the drug works could be the result. The ramdom distribution aims to but does not insure an equal distribution of patients on each group<<<<<<<<<
BRILLANTLY stated in my opinion, do you know how the FDA will wash it out?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext